COVID-19 vaccine effectiveness in patients with hematologic malignancy

Authors

Dimpy P. Shah, Mays Cancer Center at UTHealth San Antonio MD Anderson.
Pankil K. Shah, Mays Cancer Center at UTHealth San Antonio MD Anderson.
Michael A. Thompson, Advocate Aurora HealthFollow

Recommended Citation

Shah DP, Shah PK, Thompson MA. COVID-19 vaccine effectiveness in patients with hematologic malignancy. Transpl Infect Dis. 2022;24(6):e13850. doi:10.1111/tid.13850

Affiliations

Aurora Cancer Care

Abstract

• COVID‐19 vaccine response → HM

• Breakthrough infections → HM>solid

• Vaccine effectiveness → Population studies urgently needed

• Early #COVID19CP could be lifesaving in immunocompromised HM pts

Type

Editorial

PubMed ID

35584967